K A Krolick - Concepedia

Author

K A Krolick

The University of Texas Health Science Center at San Antonio

Also Known As

K A Krolick, K Krolick, K. A. Krolick, K. KROLICK, K. Krolick, K.A. Krolick, KeithA. Krolick, M De Baets

Publications

756

Citations

H-Index

Concepts

All Affiliations

The University of Texas Health Science Center at San Antonio The University of Texas Southwestern Medical Center Bipar

About

K A Krolick is an author at The University of Texas Health Science Center at San Antonio specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	11	490
2	Allergy	4	4	235
3	Biochemistry	2	2	25
4	Health Sciences	1	1	42
5	Natural Sciences	1	1	10

K A Krolick

Publications

722

Citations

H-Index

Page 1

	Year	Citations
Selective killing of normal or neoplastic B cells by antibodies coupled to the A chain of ricin. K A Krolick, C. L. Villemez, Peter C. Isakson, Proceedings of the National Academy of Sciences Chain-coupled Anti-idiotype AntibodyImmunocytochemical TechniqueApoptosisImmunologyPathology	1980	166
In vivo therapy of a murine B cell tumor (BCL1) using antibody-ricin A chain immunotoxins. K A Krolick, J W Uhr, Shimon Slavin, The Journal of Experimental Medicine ImmunologyPathologySubstantial RemissionImmunotherapyTumor Biology	1982	121
Determinant selection in murine experimental autoimmune myasthenia gravis. Effect of the bm12 mutation on T cell recognition of acetylcholine receptor epitopes A J Infante, Patricia A. Thompson, K A Krolick, The Journal of Immunology	1991	55
The effect of anti-immunoglobulin antibodies on the <i>in vitro</i> proliferation and differentiation of normal and neoplastic murineB cells. Peter C. Isakson, K A Krolick, J W Uhr, The Journal of Immunology	1980	52
Murine B Cell Leukemia (BCL1): Organ Distribution and Kinetics of Growth as Determined by Fluorescence Analysis with an Anti-Idiotypic Antibody K A Krolick, Peter C. Isakson, J W Uhr, The Journal of Immunology Mixed-phenotype Acute LeukemiaImmunologyImmunotherapyHematological MalignancyAnti-idiotypic Antibody	1979	42
Selective in vitro inhibition of an antibody response to purified acetylcholine receptor by using antigen-ricin A chain immunotoxin. Colleen A. Olsberg, Terry M. Mikiten, K A Krolick The Journal of Immunology ImmunologyAntigen ProcessingAntibody ResponsePeptide ScienceImmunotherapeutics	1985	37
T cells reactive with a small synthetic peptide of the acetylcholine receptor can provide help for a clonotypically heterogeneous antibody response and subsequently impaired muscle function. Trai‐Ming Yeh, K A Krolick The Journal of Immunology	1990	36
Preferential use of a T cell receptor V beta gene by acetylcholine receptor reactive T cells from myasthenia gravis-susceptible mice A J Infante, Henrique Levcovitz, Vernita Gordon, The Journal of Immunology	1992	36
Clonotypic analysis of anti-acetylcholine receptor antibodies from experimental autoimmune myasthenia gravis-sensitive Lewis rats and experimental autoimmune myasthenia gravis-resistant Wistar Furth rats Thomas E. Zoda, Trai‐Ming Yeh, K A Krolick The Journal of Immunology	1991	35
Specific killing of a human breast carcinoma cell line by a monoclonal antibody coupled to the A-chain of ricin K A Krolick, Dorothy Yuan, E S Vitetta Cancer Immunology Immunotherapy Breast OncologyMedicineImmunologyPathologyBreast Cancer	1981	35

Page 1